Dr. Chong Pan Pan is highly qualified with B.Sc. (Hons) in Microbiology (2001), M.Sc. in Biochemistry (2004) and completed her Ph.D. in Tissue Engineering (2013). After that, she worked as a post-doctoral research fellow (2013-2016) and was later inducted as a senior lecturer (2016-present) at the National Orthopaedic Centre of Excellence in Research and Learning (NOCERAL), Department of Orthopaedic Surgery, Faculty of Medicine, University of Malaya (UM), Malaysia. Additionally, she is in charge of setting up the Good Manufacturing Practice (GMP) Laboratory in NOCERAL. She has also been put in charge of the newly provided clinical service using platelet-derived extracellular vesicles (P-EVs) to treat lateral epicondylitis, plantar fasciitis, osteochondral defect, delayed union, knee osteoarthritis, etc. The P-EVs service is provided in the University Malaya Medical Centre (UMMC) and the University Malaya Specialist Centre (UMSC). Her research interest involves the current and innovative area of tissue engineering and manipulating adult mesenchymal stem cells (MSCs) for future use as biological therapies for poorly regenerating tissues. Her work focuses on driving the adult MSCs from bone marrow, peripheral blood, and adipose tissue along chondrogenic lineages for later transplantation to replace worn-out joint cartilage in patients suffering from joint disorders, including trauma or osteoarthritis. To attest to her work, Dr. Chong has published in several high-quality (Q1/high impact factor) peer-reviewed journals and presented her works extensively and globally at numerous international conferences. At that time, she also won several awards, including top prizes at the regional level, such as the Young Investigator Awards, Young Investigator Best Paper Award, L’Oréal Malaysia for Women in Science, Best Poster/Oral Presentations and travel fellowships, etc. In addition, she has participated in several biotechnology exhibitions and business idea competitions. Furthermore, she won many innovation awards for her work on MSCs and P-EVs as biological therapies for tissue regenerations. She has also developed intellectual property related to the novel work, which has been successfully patented.